HELX

Franklin Templeton$41.11+0.08 (+0.19%)
AUM $30.8MER 0.50%NAV $41.06Holdings 63

Price Chart

Key Statistics

Previous Close

$41.03

Day Range

$41.11$41.11

52-Week Range

$29.85$43.51

Avg Volume

1.1K

Dividend Yield

0.43%

Expense Ratio

0.50%

AUM

$30.8M

Shares Outstanding

750.1K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare96.54%
Basic Materials2.63%
Technology0.83%

Country Allocation

CountryWeight %
United States89.24%
Netherlands2.25%
Germany2.15%
United Kingdom1.96%
Ireland1.49%
Switzerland1.23%
South Korea1.12%
Denmark0.55%
Other0.01%

Fund Information

Category
Healthcare
Inception Date
Feb 25, 2020
Exchange
BATS
Description
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Similar ETFs

SymbolNameAUM
SCHDSchwab U.S. Dividend Equity ETF$110.53B
IWMiShares Russell 2000 ETF$77.55B
XLVState Street Health Care Select Sector SPDR ETF$43.25B
VHTVanguard Health Care ETF$20.90B
VTWOVanguard Russell 2000 ETF$17.40B

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund issued by Franklin Templeton that launched on Feb 25, 2020. It currently manages $30.8M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 63 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 48.4% of the fund

RankSymbolNameWeight %SharesMarket Value
1GHGUARDANT HEALTH INC9.47%18,136$3.0M
2NTRANATERA INC8.72%8,227$2.7M
3KRYSKRYSTAL BIOTECH INC5.69%5,096$1.8M
4LGNDLIGAND PHARMACEUTICALS4.41%4,768$1.4M
5ADPTADAPTIVE BIOTECHNOLOGIES4.36%55,667$1.4M
6TWSTTWIST BIOSCIENCE CORP3.65%9,069$1.1M
7BBIOBRIDGEBIO PHARMA INC3.43%14,066$1.1M
8TVTXTRAVERE THERAPEUTICS INC3.22%15,153$1.0M
9VRTXVERTEX PHARMACEUTICALS IN2.77%1,655$862K
10CTVACORTEVA INC2.67%9,800$831K
11MEDPMEDPACE HOLDINGS INC2.66%1,415$830K
12UTHRUNITED THERAPEUTICS CORP2.49%1,532$776K
13LLYELI LILLY & CO2.32%643$723K
14REGNREGENERON PHARMACEUTICALS2.23%862$696K
15RGENREPLIGEN CORP1.89%3,569$589K
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
+0.19%
1W
-2.15%
1M
+0.58%
3M
+14.44%
6M
+26.23%
YTD
+12.36%
1Y
+35.43%
3Y
+37.35%
5Y
-26.80%

Moving Averages

20-Day MA

$42.07

Below 20-Day MA
50-Day MA

$40.76

Above 50-Day MA
200-Day MA

$36.61

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$43.51

Current Price

$41.11

52-Week Low

$29.85

$29.85$43.51

Current Yield

0.43%

Annual Dividend

$0.2654

Frequency

1x/year

Last Ex-Date

Dec 30, 2025

Dividend History

Ex-DateAmountPay Date
Dec 30, 2025$0.1433Jan 8, 2026
Dec 30, 2021$0.0040Jan 7, 2022
Dec 30, 2021$0.0039Jan 7, 2022
Dec 13, 2021$0.1141Dec 21, 2021
Dec 13, 2021$0.1140Dec 21, 2021
Dec 14, 2020$0.0520Dec 23, 2020
Dec 14, 2020$0.0518Dec 23, 2020

Dividend Payments Over Time

Category Comparison

MetricHELXHealthcare(254 ETFs)Genomics(11 ETFs)
Fund Info
Expense Ratio0.50%0.62%0.61%
AUM$30.8M$1.73B$270.8M
Dividend Yield0.43%3.97%39.63%
Avg Volume1.1K364.4K353.0K
Holdings6316050
Performance
1-Month Return+1.20%-2.86%+1.97%
6-Month Return+19.27%+7.23%+19.40%
YTD Return+12.89%+10.59%+24.02%
1-Year Return+11.31%+8.50%+18.95%

Compare with Another ETF

Search for an ETF to compare with HELX:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.